Alex Goldberg

NASDAQ Gainers Watch List: Qlik Technologies, Inc. (NASDAQ:QLIK) and Celldex Therapeutics, Inc. (NASDAQ:CLDX) Added to Equity Profile Report's NASDAQ Gainers Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 12/16/2013 -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding Qlik Technologies, Inc. (NASDAQ:QLIK) and Celldex Therapeutics, Inc. (NASDAQ:CLDX).

Qlik Technologies, Inc. (NASDAQ:QLIK) a company that engages in the development, commercialization, and implementation of software products and related services for user-driven business intelligence that enables customers to make business decisions primarily in the Americas, Europe, the Asia-Pacific region, and Africa closed up in its previous session (+4.82%) on 1,414,173 shares traded. Qlik Technologies, Inc. (NASDAQ:QLIK) is currently up (+26.62%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Qlik Technologies, Inc. (NASDAQ:QLIK)

Celldex Therapeutics, Inc. (NASDAQ:CLDX) a biopharmaceutical company that focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States closed up in its previous session (+1.26%) on 2,313,959 shares traded. Celldex Therapeutics, Inc. (NASDAQ:CLDX) is currently up (+258.18%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Celldex Therapeutics, Inc. (NASDAQ:CLDX)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com